18 h, 3 h before LPS injection, both groups were pretreated with ulinastatin (100,000 U/kg, dissolved in normal saline of 5 ml)and NS (normal saline, 5 ml), respectively.
Both groups were pretreated with vaginal estradiol for 14 days.
In both experiments, cells were pretreated with drug for 1 h, stimulated with TNFα (10 ng/ml) and assayed for luciferase activity 3 h later.
To explore the involvement of MEK/MAPK signaling in MG132-mediated Bim regulation, both HMC-1 subclones were pretreated with 40 μM of the MEK inhibitor PD98059 before adding MG132.
In contrast, when cells were pretreated with both LPA (for AJ disassociation) and LiCl (for Wnt pathway activation), β-catenin accumulated in the nucleus (Figure 4A), at the time point (90 min) when AJ dissociation begins (see Figure 1).
This increase was not significantly altered when fibroblasts were pretreated with both AKT and p38 MAPK inhibitors simultaneously (161%±7.1% increase), unlike that seen in fibroblasts treated simultaneously with ERK1/2 (PD98059) and p38 MAPK (SB202190) inhibitors (172%±6.8% increase with ERK1/2 inhibitor vs. 14% ±6.6%increase with ERK1/2 and p38 MAPK inhibitor).
To examine whether the increased CM-DCFH oxidation observed in fibers from old mice was potentially due to a diminished ability to detoxify the major ROS, H2O2, through the reduced muscle GSH content, fibers from both young and old mice were pretreated with GSHEE to elevate muscle GSH content.
Similar to dicumylperoxide, we showed that resveratrol prevented inhibition of GJIC by PFOA to a greater level than either D609 or U0126 alone, but similar to the level of GJIC recovery seen when cells were pretreated with both D609 and U0126.
To investigate whether the accumulation of myeloid cells augments the lung metastasis of tumor cells, both WT and HO-1+/− mice were pretreated with B16F10-CM for 10 days, followed by i.v. injection of B16F10 cells.
Both the suspended and the precipitated parts were pretreated with LHW.
